Free shipping— Canada $250+ CAD
PUFFINPEPTIDES
Voting candidateTHYMOSIN ALPHA-1 research compound previewCatalogue preview · final packaging and presentation may vary if stocked

Five choices across your ballotUse votes only for compounds you would consider ordering

One vote per compoundEach candidate can be selected once on this browser

Flexible interest signalRemove or reassign a vote whenever you like

Help choose what Puffin stocks next
Longevity Research

THYMOSIN ALPHA-1

Thymosin alpha-1—also called thymalfasin—is a 28-amino-acid peptide derived from prothymosin alpha. It is studied in T-cell, dendritic-cell, innate-immune, and cytokine-response models.

Voting round open One active vote per compound
Your ballot0 of 5 votes used

Loading your saved choices…

Interest onlyA vote is not an order, preorder, reservation, payment, or guarantee that this compound will be stocked.

THYMOSIN ALPHA-1 is currently being evaluated through customer voting and is not available to order. Final product specifications and batch documentation will be published only if it joins the catalogue.

Catalogue statusVoting candidate
CategoryLongevity Research
Research focusT-cell response models
Ballot allowanceOne vote
Research guide

Understanding Thymosin Alpha-1

Explore the science, research focus, and key information behind this compound.

What is Thymosin Alpha-1?

Thymosin alpha-1 is a focused research compound for connecting innate and adaptive immune signalling.

What Researchers Study

Researchers examine T-cell response models, Innate-immune signalling, and Cytokine-pathway research.

How Thymosin Alpha-1 Works

Rather than one exclusive receptor, thymosin alpha-1 appears to influence pattern-recognition, antigen-presentation, T-cell maturation, and cytokine networks depending on the model. In plain language, it is an immune-regulatory peptide, not a simple immune “booster.”

Research at a Glance

Human studies exist, but conclusions vary by disease and regimen. Trials have explored hepatitis, infection, cancer-support, and immune settings. The heterogeneity makes a universal immune-benefit statement inaccurate. Immune regulation is more accurate than immune boosting. The peptide can alter several innate and adaptive signals. Direction and relevance depend on the starting immune state and the model being studied. Regional approval is not global approval. A regulator approves a defined product, manufacturer, indication, route, and label. The peptide name alone does not carry that status worldwide.

Read the full Thymosin Alpha-1 evidence guideStudy design, primary sources, limitations, and unanswered questions.Open guide
Research-use statement

If this candidate is added to the catalogue, it would be offered for controlled laboratory research only. It is not for human consumption and is not represented as a medicine, treatment, supplement, or substitute for an approved product.